NEW YORK, Oct. 13, 2016 /PRNewswire/ -- The global neurovascular intervention market is poised to reach nearly US$ 4 Billion by 2021. The market growth is attributed to factors such as an increased adoption of neurovascular devices, ageing population, rising prevalence of cerebrovascular diseases, technological advancements and deal making activity globally. However, the factors such as regulatory standards and compliance, unmet needs and a dearth of skilled neurosurgeons are restraining the growth of neurovascular interventional market.
By Device Category Neurovascular Intervention Market Analysis -
In terms of device category, Coil represents the largest market for neurovascular intervention controlling XX% share in 2015. Coil segment is facing increased competition from the emerging Carotid Stent, Micro wire/Catheter and Clot Removal device. The increasing adoption of emerging technologies such as flow diverters is likely to take market share away from the stent-assisted and balloon-assisted coiling markets. The coil assist balloon captured smallest share of the neurovascular intervention market.
By Disease Segment Neurovascular Intervention Market Analysis - Aneurysm disease segment accounts for the largest share of the global neurovascular intervention market. Arteriovenous Malformation (AVM) captures the second largest share of the total neurovascular intervention market, being followed by ischemic stroke. Intracranial atherosclerotic disease (ICAD) captured least share of the neurovascular intervention market.
Neurovascular Intervention Market Country Analysis - United States is at the forefront of neurovascular intervention market, and is likely to remain the leader throughout the forecasting period. Japan is the second leading market for neurovascular intervention being followed by China. In European region, Germany and France are leading the way in neurovascular intervention market and are competing closely with each other to grab maximum share of the pie. In Latin American countries, Brazil accounted for XX% share of the global neurovascular intervention market in 2015. Italy, Spain, United Kingdom and India represents a major market growth area.
Neurovascular Intervention Market Company Analysis - Medtronic and Stryker dominated the global neurovascular intervention market. They together accounted for over 45% share of the global neurovascular intervention market in 2015. DePuy Synthes captured third highest share of the total neurovascular intervention market in 2015, while Terumo Corporation and Penumbra Inc. are competing closely with each other to capture maximum share of the pie.
iGATE RESEARCH report titled "Neurovascular Intervention Market (by Device Category, Disease Segment, Country Wise and Company) and Forecast to 2021 - Global Analysis" provides a comprehensive assessment of the fast-evolving, high-growth global neurovascular intervention market. This report covers various aspects of the neurovascular intervention market including Device Category, Disease Segment, Country Wise Market, Company Sales and Product Portfolio Analysis, Competitive Landscape of Major Neurovascular Companies, and the Growth Drivers and Challenges influencing global neurovascular intervention market.
This 124 Page report with 61 Figures and 10 Tables has been analyzed from 8 viewpoints:
1. By Device Category - Global Neurovascular Intervention Market and Forecast (2009 - 2021)
2. By Disease Segment - Global Neurovascular Intervention Market and Forecast (2010 - 2021)
3. By Country - Neurovascular Intervention Market and Forecast (2013 - 2021)
4. Global Neurovascular Intervention Market - Company Analysis
5. Neurovascular Intervention Market - Major Deals
6. Neurovascular Intervention Market - Major Products Approval Status
7. Competitive Landscape of Major Neurovascular Companies
8. Neurovascular Intervention Market - Driving Factors and Challenges
Global Neurovascular Intervention Market and Forecast - 8 Device Category Analysis
2. Carotid Stent
3. Clot Removal Device
4. Liquid Embolic
5. Coil Assist Balloon
6. Coil Assist Stent
7. Flow Diverter Stent
8. Micro wire/Catheter
Global Neurovascular Intervention Market and Forecast - 4 Disease Segment Analysis
2. Intracranial atherosclerotic disease (ICAD)
3. Ischemic Stroke
4. Arteriovenous Malformation (AVM)
Neurovascular Intervention Market and Forecast - 10 Countries Analysis
1. United States
Global Neurovascular Intervention Market and Forecast - 6 Companies Analysis
3. Terumo Corporation
4. DePuy Synthes
5. Penumbra Inc.
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
Read the full report: http://www.reportlinker.com/p04214613-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/neurovascular-intervention-market-by-device-category-disease-segment-country-wise-and-company-and-forecast-to-2021---global-analysis-300344724.html